Drug Shortage Report for MYLAN-BUPROPION XL

Last updated on 2020-07-01 History
Report ID 110465
Drug Identification Number 02382083
Brand name MYLAN-BUPROPION XL
Common or Proper name BUPROPION
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-30
Estimated end date 2020-06-30
Actual end date 2020-06-30
Shortage status Resolved
Updated date 2020-07-01
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-07-01 English Compare
v20 2020-06-30 French Compare
v19 2020-06-30 English Compare
v18 2020-06-25 French Compare
v17 2020-06-25 English Compare
v16 2020-06-17 French Compare
v15 2020-06-17 English Compare
v14 2020-06-10 French Compare
v13 2020-06-10 English Compare
v12 2020-06-03 French Compare
v11 2020-06-03 English Compare
v10 2020-05-06 French Compare
v9 2020-05-06 English Compare
v8 2020-04-29 French Compare
v7 2020-04-29 English Compare
v6 2020-04-21 French Compare
v5 2020-04-21 English Compare
v4 2020-04-07 French Compare
v3 2020-04-07 English Compare
v2 2020-04-02 French Compare

Showing 1 to 20 of 21